SPI is excited to announce its role in co-organizing the PREVENTABLE Project’s Midterm Conference and PrevenTalk 2, taking place on 3-4 October 2024 in Rouen, France, in collaboration with EHMA, the project management team (i3S), and Rouen Partners—CHU Rouen and Centre Henri-Becquerel (CHB).
The midterm conference gathered experts and stakeholders from across Europe to explore cutting-edge research on Rare Tumour Risk Syndromes (RTRS), health economics, and healthcare innovation. PrevenTalk 2 focused on the Strengths, Weaknesses, Opportunities, and Threats (SWOT) of managing and treating RTRS, providing a platform for dialogue among clinicians, researchers, and policymakers.
With both in-person and virtual participation options, the hybrid format ensures that key discussions on improving patient outcomes and addressing the challenges in RTRS management reach a broad and engaged audience.
The event was closed with the consortium meeting where SPI provided an update and progress of Work Package 6: Dissemination, Exploitation and Communication.
We look forward to our next collaboration in shaping the future of Rare Tumour Risk Syndromespathways of care!
